These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists. Capasso A, Sorrentino L, Pinto A. Eur J Pharmacol; 1998 Oct 23; 359(2-3):127-31. PubMed ID: 9832382 [Abstract] [Full Text] [Related]
28. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF. J Pharmacol Exp Ther; 1984 Aug 23; 230(2):341-8. PubMed ID: 6086883 [Abstract] [Full Text] [Related]
29. Immunomodulatory activity of mu- and kappa-selective opioid agonists. Taub DD, Eisenstein TK, Geller EB, Adler MW, Rogers TJ. Proc Natl Acad Sci U S A; 1991 Jan 15; 88(2):360-4. PubMed ID: 1846441 [Abstract] [Full Text] [Related]
30. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists. Kamei J, Ohhashi Y, Aoki T, Kawasima N, Kasuya Y. Brain Res; 1992 Feb 07; 571(2):199-203. PubMed ID: 1319265 [Abstract] [Full Text] [Related]
32. Inhibition of airway constriction by opioids is different down the isolated bovine airway. Zappi L, Song P, Nicosia S, Nicosia F, Rehder K. Anesthesiology; 1997 Jun 07; 86(6):1334-41. PubMed ID: 9197303 [Abstract] [Full Text] [Related]